CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related deaths worldwide. This study investigated the relationship between cyclin-dependent kinase inhibitor (CDKN)3 and prognosis and pathological characteristics in HCC patients to determine whether it could be us...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wei, Fang, Shuo, Cai, Guanhe, Dai, Jialiang, Lin, Guotai, Ye, Qiurong, Miao, Huilai, Chen, Ming, Tan, Xiaoyu, Chen, Nianping, Liu, Xiaoguang, Li, Mingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388118/
https://www.ncbi.nlm.nih.gov/pubmed/32721244
http://dx.doi.org/10.1177/0300060520936879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388118/
https://www.ncbi.nlm.nih.gov/pubmed/32721244
http://dx.doi.org/10.1177/0300060520936879

Ejemplares similares